The impact of overweight and obesity on pediatric medical expenditures

Davene R Wright1, Lisa A Prosser

  • 1Department of Pediatrics, University of Washington, Seattle, WA, USA, davene.wright@seattlechildrens.org.

Insights

Overweight and obese children incur slightly higher medical costs, but not significantly more than normal-weight peers. This study examines weight-related pediatric healthcare expenditures and use trends.

Area of Science:

  • Pediatric Health Economics
  • Public Health Research
  • Obesity Studies

Background:

  • Inconsistent findings exist regarding the association between childhood overweight/obesity and medical expenditures in the US.
  • Previous research is difficult to compare due to varying methodologies and sample populations.

Purpose of the Study:

  • To investigate if methodological variations or evolving trends influence estimates of the link between weight status and pediatric medical costs.
  • To analyze the impact of overweight and obesity on healthcare expenditures and utilization among US children.

Main Methods:

  • Analysis of 2006-2010 US Medical Expenditure Panel Surveys for individuals aged 6-17.
  • Utilized a two-part regression model to predict total annual medical expenditures, controlling for demographic and socioeconomic factors.
  • Employed Poisson and logistic regression to compare healthcare use (e.g., prescription drugs, visits) between normal weight, overweight, and obese youth.

Main Results:

  • Overweight and obese youth exhibited higher medical expenditures than normal-weight youth, though the difference was not statistically significant.
  • Obese adolescents showed increased use of prescription drugs and healthcare visits, but this translated to only marginally higher costs.
  • Results remained consistent across different methodological assumptions.

Conclusions:

  • Findings may indicate emerging trends in healthcare utilization patterns among obese youth.
  • Further research is needed to explore potential underuse of services by obese youth and the long-term economic impact of sustained obesity.
  • The study highlights the complexity of quantifying the financial burden of childhood obesity.
Abstract

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
368
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
440
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
324
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410
Stress Prevention and Stress Management Techniques IV01:26

Stress Prevention and Stress Management Techniques IV

Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
365